Chimeric Therapeutics (ASX:CHM) - Webinar Presentation Company Presentations by Finance News Network March 01, 2024 02:44 PM Email Alerts for: ASX:CHM Jennifer Chow - CEO & Managing Director - Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
